Document is current

Article History

Received: 7 September 2024

Accepted: 24 December 2024

First Online: 15 January 2025

Competing interests

: The authors declare the following competing interests: J.E.F., E.A.I., D.M.C., D.N., N.A., A.B.S., T.F.M., and S.D.G. are named inventors on the below patent and patent application which include intellectual property regarding the use of transferrin binding protein B as a vaccine antigen for protection against N. gonorrhea: 1. Schryvers, A.B., Moraes, T., and Gray-Owen, S.D. Immunogenic compositions and vaccines derived from bacterial surface receptor proteins. International Patent Application PCT/CA2014/051146. Filed December 1, 2014. PCT National Phase Filings in: US, Canada, Europe, China, Australia, Japan, India, Brazil, New Zealand, Eurasia, South Korea. US Patent #10149900B2 issued December 11, 2018. Australian Patent 2014360590 was granted on August 28, 2019. Eurasian Patent 201691140 was granted on April 4, 2021. New Zealand Patent 721121 was granted on December 1, 2021. European Patent #3077512 was granted on February 9, 2022. South Korea patent #10-2507993 was granted on March 6, 2023. India Patent #424510 was granted on March 9, 2023. 2. Fegan, J., Islam, E., Curran, D., Ng, D., Au, N., Schryvers, A.B., Moraes, T.F. and Gray-Owen, S.D. Vaccines and methods for the treatment of Neisseria gonorrhoeae infections. US Patent and Trademark Office #63/691,519, filed September 6, 2024. All other authors (E.G.C., J.J.Z., and J.L.) declare no competing interests.